I received an interesting question by e-mail recently, which brought up several good points to review. The author asked:
"Can a patient use metformin after a heart attack (after 12 years of using metformin) assuming the patient has good renal function? My question is if metformin should be avoided forever after an acute myocardial infarction or just temporarily withheld after the heart attack in a patient with an adequate renal and liver function (also without congestive heart failure or hypersensitivity to metformin)."
I answered:
"According to the USPI (the "label") for Glucophage brand of metformin, GLUCOPHAGE and GLUCOPHAGE XR are contraindicated [should not be used] in patients with: Renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels =1.5 mg/dL [males], =1.4 mg/dL [females] or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia.
"And in the Precautions Section, it states:
"Cardiovascular collapse (shock) from whatever cause, acute congestive heart failure, acute myocardial infarction [heart attack] and other conditions characterized by hypoxemia [low oxygen levels in the bloodstream] have been associated with lactic acidosis... When such events occur in patients on GLUCOPHAGE or GLUCOPHAGE XR therapy, the drug should be promptly discontinued."
As I pointed out to the writer, this label is poorly worded. I think what's meant is that in recent (acute) myocardial infarction (heart attack), there's an increased risk of renal insufficiency (kidneys not working well) and/or an increased risk of low oxygen levels in the bloodstream, and in either case, an increased risk of lactic acidosis. And it's lactic acidosis that's well-known to be the biggest risk with metformin. Not heart attacks: indeed studies have shown that metformin therapy can actually decrease the likelihood of having a heart attack!
I continued: "As such, if you're beyond the "acute" phase of your myocardial infarction, it's probably reasonable to resume your metformin. Discuss with your physician!"
As the label states, lactic acidosis is a rare, but serious, metabolic complication that can occur due to metformin accumulation; ... when it occurs, it is fatal in approximately 50% of cases. It's much more likely in patients who have limited kidney function, hence the concern that anything that can increase the likelihood of putting stress on the kidneys, such as an acute myocardial infarction (heart attack), can increase the chance of lactic acidosis occurring. So the warning, as I understand it, is to avoid using metformin temporarily while the chance of limited kidney function ("renal dysfunction"), if the kidney situation is likely to be temporary.
But that brings up another problem: many people with diabetes have limited kidney function due to the combination of long-duration diabetes plus advancing age. This can be spotted easily on blood testing, when the blood test called "creatinine" is elevated in the absence of acute events such as a recent heart attack. As the label mentions, if the blood level of creatinine is above 1.5 mg/dL in men, or above 1.4 mg/dL in women, the risk is high enough that metformin should not be used. (Another more sophisticated way of measuring kidney function is to collect 24 hours worth of urine, and do a blood creatinine test during the 24 hours; this test is called the"creatinine clearance".)
"Can a patient use metformin after a heart attack (after 12 years of using metformin) assuming the patient has good renal function? My question is if metformin should be avoided forever after an acute myocardial infarction or just temporarily withheld after the heart attack in a patient with an adequate renal and liver function (also without congestive heart failure or hypersensitivity to metformin)."
I answered:
"According to the USPI (the "label") for Glucophage brand of metformin, GLUCOPHAGE and GLUCOPHAGE XR are contraindicated [should not be used] in patients with: Renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels =1.5 mg/dL [males], =1.4 mg/dL [females] or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia.
"And in the Precautions Section, it states:
"Cardiovascular collapse (shock) from whatever cause, acute congestive heart failure, acute myocardial infarction [heart attack] and other conditions characterized by hypoxemia [low oxygen levels in the bloodstream] have been associated with lactic acidosis... When such events occur in patients on GLUCOPHAGE or GLUCOPHAGE XR therapy, the drug should be promptly discontinued."
As I pointed out to the writer, this label is poorly worded. I think what's meant is that in recent (acute) myocardial infarction (heart attack), there's an increased risk of renal insufficiency (kidneys not working well) and/or an increased risk of low oxygen levels in the bloodstream, and in either case, an increased risk of lactic acidosis. And it's lactic acidosis that's well-known to be the biggest risk with metformin. Not heart attacks: indeed studies have shown that metformin therapy can actually decrease the likelihood of having a heart attack!
I continued: "As such, if you're beyond the "acute" phase of your myocardial infarction, it's probably reasonable to resume your metformin. Discuss with your physician!"
As the label states, lactic acidosis is a rare, but serious, metabolic complication that can occur due to metformin accumulation; ... when it occurs, it is fatal in approximately 50% of cases. It's much more likely in patients who have limited kidney function, hence the concern that anything that can increase the likelihood of putting stress on the kidneys, such as an acute myocardial infarction (heart attack), can increase the chance of lactic acidosis occurring. So the warning, as I understand it, is to avoid using metformin temporarily while the chance of limited kidney function ("renal dysfunction"), if the kidney situation is likely to be temporary.
But that brings up another problem: many people with diabetes have limited kidney function due to the combination of long-duration diabetes plus advancing age. This can be spotted easily on blood testing, when the blood test called "creatinine" is elevated in the absence of acute events such as a recent heart attack. As the label mentions, if the blood level of creatinine is above 1.5 mg/dL in men, or above 1.4 mg/dL in women, the risk is high enough that metformin should not be used. (Another more sophisticated way of measuring kidney function is to collect 24 hours worth of urine, and do a blood creatinine test during the 24 hours; this test is called the"creatinine clearance".)
- Font size
- Email This
- Bookmark
- Thank you for your input
- Save
- RSS
- Report Abuse
